Bin Li

Director, Search & Evaluation, JAPAC at AbbVie

Committee Member

Dr. Bin Li is currently Head of Research and BD, Fosun Kit Biotechnology Co., Ltd. He was a Director, Search & Evaluation, JAPAC at AbbVie in Shanghai, responsible for search and evaluation of partnership opportunities in key therapeutic areas of immunology, oncology, neuroscience, and liver diseases. From 2008 to 2015, he was site head of AbbVie China R&D Center in Shanghai which focuses on pre-clinical drug discovery in several therapeutic disease areas including chronic kidney diseases. Prior to AbbVie, Dr. Li was Vice President, Service Biology at ChemPartner to build and lead the service biology division. Before 2007, he spent 16 years in US pharmaceutical and biotech companies, including Roche, Pfizer, Anadys, and Xceptor, with various titles from Research Scientist to Director to lead and support drug discovery research. Dr. Li received his B.S. from Lanzhou University in China in 1982, M.S. from Iowa State University in 1986, and Ph.D. from Penn State University in 1990.